Publicaciones en colaboración con investigadores/as de Institute Catalá Oncología (26)

2024

  1. “For and against” factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022

    Archives of Public Health, Vol. 82, Núm. 1

2023

  1. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer

    Molecular Cancer, Vol. 22, Núm. 1

2022

  1. Women's preference to apply shared decision-making in breast cancer screening: a discrete choice experiment

    BMJ Open, Vol. 12, Núm. 11

2021

  1. The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy

    Journal of Laryngology and Otology, Vol. 135, Núm. 11, pp. 970-975

2020

  1. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study

    International Journal of Cancer, Vol. 147, Núm. 1, pp. 277-284

  2. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial

    PLoS ONE, Vol. 14, Núm. 3

  2. Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

    Cancers, Vol. 11, Núm. 10

2017

  1. Assessment of the effects of decision aids about breast cancer screening: A systematic review and meta-analysis

    BMJ Open, Vol. 7, Núm. 10

  2. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624

  3. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (Nature Genetics (2014) 46 (736-741))

    Nature Genetics

  4. The effect of information about the benefits and harms of mammography on women's decision-making: Study protocol for a randomized controlled trial

    Trials, Vol. 18, Núm. 1

2016

  1. Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1140-1146

2014

  1. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Nature Genetics, Vol. 46, Núm. 7, pp. 736-741

2013

  1. Level of HER2 gene amplification predicts response and overall survival in her2-positive advanced gastric cancer treated with trastuzumab

    Journal of Clinical Oncology, Vol. 31, Núm. 35, pp. 4445-4452

2012

  1. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution

    Gene Therapy, Vol. 19, Núm. 11, pp. 1048-1057

2008

  1. Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families

    International Journal of Cancer, Vol. 122, Núm. 6, pp. 1422-1425

2007

  1. Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 1, pp. 276-281

  2. Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

    Journal of Medical Genetics, Vol. 44, Núm. 1, pp. 75-80

2006

  1. EPHB4 and survival of colorectal cancer patients

    Cancer Research, Vol. 66, Núm. 18, pp. 8943-8948